Scott P. Bruder's most recent trade in Bellerophon Therapeutics Inc was a trade of 14,607 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics Inc | Scott P. Bruder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 14,607 | 14,607 | - | - | Stock Options (Right to Buy) | |
| Bellerophon Therapeutics Inc | Scott P. Bruder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 29,000 | 29,000 | - | - | Stock Options (right to buy) | |
| Bellerophon Therapeutics Inc | Scott P. Bruder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2020 | 6,509 | 15,138 | - | - | Stock Option (right to buy) |